| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | KOPIN CORP - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 2 | SEC Filings | ||
| Fr | Kopin outlines $52M-$60M revenue target for 2026 amid strategic partnerships and defense market expansion | 4 | Seeking Alpha | ||
| Fr | Kopin verfehlt Umsatzprognose für Q4 2025 - Aktie gibt nach | 16 | Investing.com Deutsch | ||
| Fr | Kopin reports Q4 results | 1 | Seeking Alpha | ||
| Fr | SMOLTEK NANOTECH HOLDING AB: Smoltek's CNF-MIM technology continues to demonstrate stable performance in extended life test conducted by global capacitor manufacturer | 3 | Cision News | ||
| Do | Nanologica AB: Nanologica Announces Outcome of Rights Issue | 252 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| Do | Kopin Q4 2025 Earnings Preview | 14 | Seeking Alpha | ||
| Do | GOMSPACE GROUP AB: GomSpace joins Danish flagship project to unlock next-generation antenna performance for small satellites | 4 | Cision News | ||
| Do | Canatu Oyj: Inside information: Canatu announces updated strategy and long-term financial targets, transitioning to scalable value creation | 1.232 | GlobeNewswire (Europe) | Canatu Plc Inside information 26 March 2026 at 9:58 a.m. EET
Canatu Plc's Board of Directors has approved the company's updated strategy and long-term financial targets, which extend until the end... ► Artikel lesen | |
| Do | Nexsen accelerates global rollout for StrepSure | 1 | The Market Herald Australia | ||
| Mi | ANTEOTECH LTD: Presentation to NWR Virtual Healthcare Conference | - | ASX | ||
| Mi | Zentek Ltd: Zentek's Triera Biosciences to offer CRO services | 2 | Stockwatch | ||
| Mi | NEXSEN LIMITED: Nexsen accelerates global rollout for StrepSure | - | ASX | ||
| Mi | Zentek Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| Mi | Zentek's Triera unit to offer aptamer discovery CRO services | 2 | Investing.com | ||
| Mi | Zentek-Tochter Triera startet Auftragsforschung für Aptamer-Entwicklung | 4 | Investing.com Deutsch | ||
| Mi | Zentek Ltd.: Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification | 445 | ACCESS Newswire | Backed by an Exclusive 20-Year McMaster University License, Triera Targets High-Priority Infectious Disease and Oncology Detection Markets Across Canada, the United States, and Europe GUELPH, ON / ACCESS... ► Artikel lesen | |
| Di | ANTEOTECH LTD: Presentation to 43rd Florida International Battery Seminar | - | ASX | ||
| Di | NANOVEU LIMITED: Pitt Street Research Semiconductor Conference Presentation | - | ASX | ||
| Di | Region Group extends $100m securities buy-back - earnings update | 1 | The Motley Fool Australia |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| KOPIN | 4 | - | -7,71 % | KOPIN CORP - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | |||
| SMOLTEK NANOTECH | 1 | - | 0,00 % | SMOLTEK NANOTECH HOLDING AB: Smoltek's CNF-MIM technology continues to demonstrate stable performance in extended life test conducted by global capacitor manufacturer | |||
| ONTO INNOVATION | - | 6 | -1,12 % | Onto Innovation stock holds at Stifel on HBM customer win | |||
| NANOFOCUS | - | 3 | +1,08 % | Nanofocus: Aus in München und Berlin | Im November hat eine außerordentliche Hauptversammlung von Nanofocus beschlossen, die Aktien der Minderheitsaktionäre auf die Carl Mahr Holding zu übertragen. Dies ist der Hauptaktionär der Oberhausener.... ► Artikel lesen | ||
| FORMYCON | - | 3 | -3,59 % | FORMYCON AG: Stabilität als strategisches Signal | |||
| ANTEOTECH | - | 3 | - | ANTEOTECH LTD: Presentation to NWR Virtual Healthcare Conference | |||
| ZENTEK | - | 3 | +6,69 % | Zentek Ltd.: Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification | Backed by an Exclusive 20-Year McMaster University License, Triera Targets High-Priority Infectious Disease and Oncology Detection Markets Across Canada, the United States, and Europe GUELPH, ON / ACCESS... ► Artikel lesen | ||
| SOLESENCE | - | 2 | -1,19 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | ||
| VEECO INSTRUMENTS | - | 2 | -0,64 % | Axcelis Technologies, Inc.: Axcelis Stockholders Approve Merger with Veeco | BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all... ► Artikel lesen | ||
| RIBER | - | 2 | -4,03 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| Es sind keine Aktien verfügbar, die den gewählten Kriterien entsprechen. | |||||||||